|
Abdilla N, Tormo MC, Fabia MJ, Chaves FJ, Saez G, Redon J. (2007). Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension. J Hum Hypertens. 21(1), 68-75.
Abdul-Ghani MA, DeFronzo RA.(2008). Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus. Curr Diab Rep 3,173-8.
Abuja PM. (1991). Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein. FEBS Lett 446, 305-8.
Adiels M, Olofsson SO, Taskinen MR, Borén J. (2008). Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28, 1225-36.
Ames BN, Cathcart R, Schwiers E, Hochstein P. (1981). Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 78, 6858-62.
Annex BH, Williams RS. (1990). Mitochondrial DNA structure and expression in specialized subtypes of mammalian striated muscle. Mol Cell Biol 10, 5671–5678
.
Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 257,79-83.
Ashby DT, Rye KA, Clay MA, Vadas MA, Gamble JR, Barter PJ.(1998). Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler Thromb Vasc Biol 18, 1450-5.
Assmann G, Nofer JR. (2003). Atheroprotective effects of high-density lipoproteins. Annu Rev Med 54, 321-41.
Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP, Holloszy JO. (2002). Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 16, 1879-86.
Ballard JW, Melvin RG, Miller JT, Katewa SD. (2007). Sex differences in survival and mitochondrial bioenergetics during aging in Drosophila. Aging Cell 5, 699-708.
Berg AH, Lin Y, Lisanti MP, Scherer PE. (2004). Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. Am J Physiol Endocrinol Metab 287, E1178-88.
Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7, 947-53.
Bhargava SK, Sachdev HS, Fall CH, Osmond C, Lakshmy R, Barker DJ, Biswas SK, Ramji S, Prabhakaran D, Reddy KS. (2004). Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 350,865-75.
Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, Travia D, Zenti MG, Branzi P, Santi L, Muggeo M. (1996). Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 20, 975-80.
Brown TA, Clayton DA. (2002). Release of replication termination controls mitochondrial DNA copy number after depletion with 2'',3''-dideoxycytidine. Nucleic Acids Res 30, 2004-10.
Byrne JA, Grieve DJ, Cave AC, Shah AM. (2003). Oxidative stress and heart failure. Arch Mal Coeur Vaiss 96, 214-21.
Carrodeguas JA, Theis K, Bogenhangen DF, Kisker C. (2001). Crystal structure and deletion analysis show that the accessory subunit of mammalian DNA polymerase gamma, Pol gamma B, functions as a homodimer. Mol Cell 7, 43-54
Chan DC.(2007). Mitochondrial dynamics in disease. N Engl J Med 356, 1707-9.
Chan DC, Watts GF, Ooi EM, Ji J, Johnson AG, Barrett PH. (2008). Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome. Arterioscler Thromb Vasc Biol 28, 1831-7.
Chan DC, Watts GF, Redgrave TG, Mori TA, Barrett PH. (2002). Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metabolism 51, 1041-6.
Chien KL, Hsu HC, Lee YT, Chen MF. (2008). Renal function and metabolic syndrome components on cardiovascular and all-cause mortality. Atherosclerosis 197, 860-7.
Cho YM, Park KS, Lee HK. (2007). Genetic factors related to mitochondrial function and risk of diabetes mellitus. Diabetes Res Clin Pract 77 Suppl 1, S172-7.
Clayton DA. (1998). Nuclear-mitochondrial intergenomic communication. Biofactors 7, 203-205.
Clayton DA. (1982). Replication of animal mitochondrial DNA. Cell 28, 693-705.
Clayton DA. (1992). Transcription and replication of animal mitochondrial DNAs. Int Rev Cytol 141, 217-232.
Curtiss LK, Bonnet DJ, Rye KA. (2000). The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. Biochemistry 39, 5712-21.
Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T. (2003). Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care 26, 2015-20.
Dicker-Brown A, Fonseca VA, Fink LM, Kern PA. (2001). The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes. Atherosclerosis 158, 297-301.
DiMauro S, Schon EA.(2003). Mitochondrial respiratory chain diseases. N Engl J Med 348,2656-68.
Diniz YS, Rocha KK, Souza GA, Galhardi CM, Ebaid GM, Rodrigues HG, Novelli Filho JL, Cicogna AC, Novelli EL. (2006). Effects of N-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats. Eur J Pharmacol 543(1-3), 151-7.
Dong F, Li Q, Sreejayan N, Nunn JM, Ren J. (2007). Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis. Diabetes 56, 2201-12.
Douce R, Bourguignon J, Macherel D, Neuburger M. (1994). The glycine decarboxylase system in higher plant mitochondria: structure, function and biogenesis. Biochem Soc Trans 22, 184-8.
Doughan AK, Harrison DG, Dikalov SI. (2008). Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102, 488-96.
Duncan JG, Fong JL, Medeiros DM, Finck BN, Kelly DP. (2007). Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation 115, 909-17.
Eriksson JG, Forsén T, Tuomilehto J, Winter PD, Osmond C, Barker DJ. (1999). Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 318, 427-31.
Eriksson JW. (2007). Metabolic stress in insulin''s target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance. FEBS Lett 581, 3734-42.
Finck BN, Kelly DP. (2006). PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116, 615-22.
Fleming DM, Schellevis FG, van Casteren V. (2004). The prevalence of known diabetes in eight European countries. Eur J Public Health 14, 10-14.
Fonseca V, Dicker-Brown A, Ranganathan S, Song W, Barnard RJ, Fink L, Kern PA. (2000). Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 49, 736-41.
Ford ES. (2004). The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173, 309-14.
Ford ES, Giles WH, Dietz WH. (2002). Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356-9.
Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752-61.
Garcin JM, Cremades S, Garcia-Hejl C, Bordier L, Dupuy O, Mayaudon H, Bauduceau B. (2006). Is hyperhomocysteinemia an additional risk factor of the metabolic syndrome? Metab Syndr Relat Disord 4, 185-95.
Gaziev AI, Shaĭkhaev GO. (2008). Lesions of the mitochondrial genome and ways of its preservation. Genetika 44﹐437-55.
Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. (2005). Uric acid and oxidative stress. Curr Pharm Des 11, 4145-51.
Gluckman PD, Hanson MA, Cooper C, Thornburg KL. (2008). Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359, 61-73.
Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Lúis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G, et al (1997). Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 277, 1775-81.
Hance N, Ekstrand MI, Trifunovic A. (2005). Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis. Hum Mol Genet 14, 1775-83.
Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A. (2004). Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89, 4963-71.
Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. (2006). Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29, 1357-62.
Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, Goodpaster B, Harris TB. (2004). The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 53, 1068-73.
Hori A, Yoshida M, Shibata T, Ling F. (2009). Reactive oxygen species regulate DNA copy number in isolated yeast mitochondria by triggering recombination-mediated replication. Nucleic Acids Res 37, 749-61.
Houstis N, Rosen ED, Lander ES. (2006). Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-8.
Hu G, DECODE Study Group. (2003). Gender difference in all-cause and cardiovascular mortality related to hyperglycemia and newly-diagnosed diabetes. Diabetologia 46, 608-17.
Isganaitis E, Jimenez-Chillaron J, Woo M, Chow A, DeCoste J, Vokes M, Liu M, Kasif S, Zavacki AM, Leshan RL, Myers MG, Patti ME. (2009). Accelerated postnatal growth increases lipogenic gene expression and adipocyte size in low-birth weight mice. Diabetes 58, 1192-200.
Jacobs RL, House JD, Brosnan ME, Brosnan JT. (1998). Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 47, 1967-70.
Jazayeri M, Andreyev A, Will Y, Ward M, Anderson CM, Clevenger W. (2003). Inducible expression of a dominant negative DNA polymerase-gamma depletes mitochondrial DNA and produces a rho0 phenotype. J Biol Chem 278, 9823-30.
Jeng JY, Yeh TS, Lee JW, Lin SH, Fong TH, Hsieh RH. (2008). Maintenance of mitochondrial DNA copy number and expression are essential for preservation of mitochondrial function and cell growth. J Cell Biochem 103,347-57.
Jeppesen J, Facchini FS, Reaven GM. (1998). Individuals with high total cholesterol/HDL cholesterol ratios are insulin resistant. J Intern Med 243, 293-8.
Johnson RJ, Rideout BA. (2004). Uric acid and diet--insights into the epidemic of cardiovascular disease. N Engl J Med 350, 1071-3.
Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. (2003). Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41, 1183-90.
Katic M, Kennedy AR, Leykin I, Norris A, McGettrick A, Gesta S, Russell SJ, Bluher M, Maratos-Flier E, Kahn CR. (2007). Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Aging Cell 6, 827-39.
Kim JA, Wei Y, Sowers JR. (2008). Role of mitochondrial dysfunction in insulin resistance. Circ Res 102, 401-14.
Kinosian B, Glick H, Garland G. (1994). Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 121, 641-7.
Kontush A, Chantepie S, Chapman MJ. (2003). Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 23, 1881-8.
Kontush A, Chapman MJ. (2006). Antiatherogenic small, dense HDL--guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med 3, 144-53.
Kronborg J, Jenssen T, Njølstad I, Toft I, Eriksen BO. (2007). Metabolic risk factors associated with serum creatinine in a non-diabetic population. Eur J Epidemiol 22, 707-13.
Kurella M, Lo JC, Chertow GM. (2005). Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16, 2134-40.
Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. (2005). Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol 70, 343-54.
Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M,Barsh GS, Clayton DA. (1998). Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18, 231-236.
Lee HC, Wei YH. (2007). Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med (Maywood) 232, 592-606.
Lee HC, Wei YH. (2005). Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol 37, 822-34.
Lee SJ, Campos H, Moye LA, Sacks FM. (2003). LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients. Arterioscler Thromb Vasc Biol 23,853-858.
Le Goff W, Guerin M, Chapman MJ. (2004). Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia. Pharmacol Ther 101, 17-38.
Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. (2000). Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106, 847-56.
Leunissen RW, Oosterbeek P, Hol LK, Hellingman AA, Stijnen T, Hokken-Koelega AC. (2008). Fat mass accumulation during childhood determines insulin sensitivity in early adulthood. J Clin Endocrinol Metab 93, 445-51.
Lewis W, Day BJ, Copeland WC. (2003). Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2, 812-822.
Lim S, Kim MS, Park KS, Lee JH, An GH, Yim MJ, Song J, Pak YK, Lee HK. (2001). Correlation of plasma homocysteine and mitochondrial DNA content in peripheral blood in healthy women. Atherosclerosis 158, 399-405.
Lim SE, Longley MJ, Copeland WC. (1999). The mitochondrial p55
accessory subunit of the human DNA polymerase gamma enhances DNA binding, promotes processive DNA synthesis, and confers N-ethylmaleimide resistance. J Biol Chem 274, 38197-38203.
Lin Y, Berg AH, Iyengar P, Lam TK, Giacca A, Combs TP, Rajala MW, Du X, Rollman B, Li W, Hawkins M, Barzilai N, Rhodes CJ, Fantus IG, Brownlee M, Scherer PE. (2005). The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 280, 4617-26.
Li SY, Yang X, Ceylan-Isik AF, Du M, Sreejayan N, Ren J. (2006). Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch. Diabetologia 49, 1434-46.
Liu CS, Tsai CS, Kuo CL, Chen HW, Lii CK, Ma YS, Wei YH. (2003). Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res 37, 1307-17.
Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L. (2002). Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome. Gynecol Endocrinol 16, 217-24.
Lusis AJ. (2000). Atherosclerosis. Nature 407, 233-41.
Maassen JA, ''t Hart LM, Ouwens DM. (2007). Lessons that can be learned from patients with diabetogenic mutations in mitochondrial DNA: implications for common type 2 diabetes. Curr Opin Clin Nutr Metab Care 10, 693-7.
Maples KR, Mason RP. (1988). Free radical metabolite of uric acid. J Biol Chem 263, 1709-12.
Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y. (2002). Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 277, 37487-91.
Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, Matsuzawa Y. (1998). Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 47, 929-33.
Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H, Ota T, Yokoyama M, Honda M, Miyamoto K, Kaneko S. (2008). Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57, 1071-7.
Muraoka S, Miura T. (2003). Inhibition by uric acid of free radicals that damage biological molecules. Pharmacol Toxicol 93, 284-9.
Murphy AN, Fiskum G, Beal MF. (1999). Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb Blood Flow Metab 19,231-45.
Nakagawa T, Tuttle KR, Short RA, Johnson RJ. (2005). Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 1, 80-6.
Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy ST, Miller NE, Fogelman AM. (2000). Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res 41, 1481-94.
Nicolson GL. (2007). Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function. J Cell Biochem 100,1352-69.
Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S. (2003). Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS 17, 1329-38.
Oda M, Satta Y, Takenaka O, Takahata N. (2002). Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 19, 640-53.
Ogura T, Matsuura K, Matsumoto Y, Mimura Y, Kishida M, Otsuka F, Tobe K. (2004). Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002. Metabolism 53, 448-53.
Ohta T, Saku K, Takata K, Nakamura R, Ikeda Y, Matsuda I. (1995). Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells. Arterioscler Thromb Vasc Biol 15, 956-62.
Onat A, Hergenç G, Keleş I, Doğan Y, Türkmen S, Sansoy V. (2005). Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome. Metabolism 54, 800-8.
Onat A, Ceyhan K, BaYar O¨ , Erer B, Sansoy V. (2002). Metabolic syndrome:
major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis 165, 285-92.
Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y. (2001). Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103, 1057-63.
Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. (1995). Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346, 1395-8.
Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. (2004). Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350,664-71.
Pietiläinen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, Keränen H, Suomalainen A, Götz A, Suortti T, Yki-Järvinen H, Oresic M, Kaprio J, Peltonen L. (2008). Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 5, e51.
Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. (1998). A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-39.
Rasmussen EL, Malis C, Jensen CB, Jensen JE, Storgaard H, Poulsen P, Pilgaard K, Schou JH, Madsbad S, Astrup A, Vaag A. (2005). Altered fat tissue distribution in young adult men who had low birth weight. Diabetes Care 28, 151-3.
Redón J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Sáez GT. (2003). Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41, 1096-101.
Relling DP, Esberg LB, Fang CX, Johnson WT, Murphy EJ, Carlson EC, Saari JT, Ren J. (2006). High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis. J Hypertens 24, 549-61.
Rhee EJ, Hwang ST, Lee WY, Yoon JH, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Sung KC. (2007). Relationship between metabolic syndrome categorized by newly recommended by International Diabetes Federation criteria with plasma homocysteine concentration. Endocr J 54, 995-1002.
Robin ED, Wong R. (1988). Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J Cell Physiol 136,507-13.
Ruotolo G, Howard BV. (2002). Dyslipidemia of the metabolic syndrome. Curr Cardiol Rep 4, 494-500.
Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, Pfeffer MA, Braunwald E. (2000). VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial. Circulation 102,1886-1892.
Salvayre R, Auge N, Benoist H, Negre-Salvayre A. (2002). Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 1585, 213-21.
Santos CX, Anjos EI, Augusto O. (1999). Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys 372, 285-94.
Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. (2007). Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293, C584-96.
Schultz RA, Swoap SJ, McDaniel LD, Zhang B, Koon EC,Garry DJ, Li K, Williams RS. (1998). Differential expression of mitochondrial DNA replication factors in mammalian tissues. J Biol Chem 273, 3447-3451.
Sehayek E, Eisenberg S. (1991). Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Biol Chem 266, 18259-67.
Seino Y, Hirose H, Saito I, Itoh H. (2009). High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men. Metabolism 58, 355-60.
Sevanian A, Hwang J, Hodis H, Cazzolato G, Avogaro P, Bittolo-Bon G. (1996). Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations. Arterioscler Thromb Vasc Biol 16, 784-93.
Shachter NS. (2001). Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol 12, 297-304.
Sherratt HS. (1991). Mitochondria: structure and function. Rev Neurol (Paris) 147,417-30.
Song J, Oh JY, Sung YA, Pak YK, Park KS, Lee HK. (2001). Peripheral blood mitochondrial DNA content is related to insulin sensitivity in offspring of type 2 diabetic patients. Diabetes Care 24,865-9.
de Souza JA, Vindis C, Hansel B, Nègre-Salvayre A, Therond P, Serrano CV Jr, Chantepie S, Salvayre R, Bruckert E, Chapman MJ, Kontush A. (2008). Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. Atherosclerosis 197, 84-94.
Sparks DL, Davidson WS, Lund-Katz S, Phillips MC. (1995). Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability. J Biol Chem 270, 26910-7.
Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR. (2005). A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54, 1926-33.
Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. (2003). Adiponectin and protection against type 2 diabetes mellitus. Lancet 361, 226-8.
Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. (1992). A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268, 877-81.
Stocker R, Keaney JF Jr. (2004). Role of oxidative modifications in atherosclerosis. Physiol Rev 84, 1381-478.
Suc I, Escargueil-Blanc I, Troly M, Salvayre R, Nègre-Salvayre A. (1997). HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler Thromb Vasc Biol 17, 2158-66.
Suliman HB, Welty-Wolf KE, Carraway M, Tatro L, Piantadosi CA. (2004). Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res 64, 279-88.
Takamura T, Misu H, Matsuzawa-Nagata N, Sakurai M, Ota T, Shimizu A, Kurita S, Takeshita Y, Ando H, Honda M, Kaneko S. (2008). Obesity Upregulates Genes Involved in Oxidative Phosphorylation in Livers of Diabetic Patients. Obesity (Silver Spring). 2008 Oct 9.
Tyynismaa H, Suomalainen A. (2009). Mouse models of mitochondrial DNA defects and their relevance for human disease. EMBO Rep 10,137-43.
Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y. (2003). Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 88,4673-6.
Urata M, Koga-Wada Y, Kayamori Y, Kang D. (2008). Platelet contamination causes large variation as well as overestimation of mitochondrial DNA content of peripheral blood mononuclear cells. Ann Clin Biochem 45(Pt 5), 513-4.
Van Linthout S, Spillmann F, Lorenz M, Meloni M, Jacobs F, Egorova M, Stangl V, De Geest B, Schultheiss HP, Tschöpe C. (2009). Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor. Hypertension 53, 682-7.
Viña J, Sastre J, Pallardó F, Borrás C. (2003). Mitochondrial theory of aging: importance to explain why females live longer than males. Antioxid Redox Signal 5, 549-56.
Viña J, Sastre J, Pallardó FV, Gambini J, Borrás C. (2008). Modulation of longevity-associated genes by estrogens or phytoestrogens. Biol Chem 389, 273-7.
Wang CS, McConathy WJ, Kloer HU, Alaupovic P. (1985). Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 75, 384-90.
Welch GN, Loscalzo J. (1998). Homocysteine and atherothrombosis. N Engl J Med 338, 1042-50.
Wellen KE, Hotamisligil GS. (2005). Inflammation, stress, and diabetes. J Clin Invest 115, 1111-9.
Weng SW, Lin TK, Liou CW, Chen SD, Wei YH, Lee HC, Chen IY, Hsieh CJ, Wang PW. (2009). Peripheral blood mitochondrial DNA content and dysregulation of glucose metabolism. Diabetes Res Clin Pract 83,94-9.
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86, 1930-5.
Williams RS. (1986). Mitochondrial gene expression in mammalian striated muscle. Evidence that variation in gene dosage is the major regulatory event. J Biol Chem 261,12390-4.
Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM. (1999). Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-24.
Xu B, Clayton DA. (1995). A persistent RNA-DNA hybrid is formed during
transcription at a phylogenetically conserved mitochondrial DNA sequence. Mol Cell Biol 15, 580-589.
Xu B, Clayton DA. (1996). RNA-DNA hybrid formation at the human
mitochondrial heavy-strand origin ceases at replication start sites: an implication for
RNA-DNA hybrids serving as primers. EMBO J 15, 3135-3143.
Yakes FM, Van Houten B. (1997). Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A 94, 514-9.
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7, 941-6.
Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG. (2005). Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69, 928-33.
|